MNPO news

Latest 1 stories · newest May 29, 2026

MNPO

Monopar Therapeutics files 8-K exhibit with limited discernible content

Monopar Therapeutics submitted an SEC 8-K filing with exhibit 99.1 containing minimal substantive information. Without clear filing details, market impact and company developments cannot be assessed.

Other May 29, 2026 sentiment 0.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same MNPO feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/MNPO/newsSTART FREE